Hyperglycemia alters refractory periods in human diabetic neuropathy

Clinical Neurophysiology

Volumn 115, Issue 11, 2004, Pages 2525-2529

  Misawa, Sonoko ^a   Kuwabara, Satoshi ^a   Ogawara, Kazue ^a   Kitano, Yukiko ^a   Yagui, Kazuo ^a   Hattori, Takamichi ^a  

^a CHIBA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Diabetic neuropathy; Refractoriness; Refractory period; Sodium channel

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); HEMOGLOBIN A1C; SODIUM CHANNEL;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DIABETIC NEUROPATHY; DISEASE ASSOCIATION; ENZYME ACTIVITY; FEMALE; HUMAN; HYPERGLYCEMIA; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; NERVE CONDUCTION; NERVE EXCITABILITY; PRIORITY JOURNAL; REFRACTORY PERIOD; SODIUM CURRENT;

ADULT; AGED; AGED, 80 AND OVER; AXONS; CASE-CONTROL STUDIES; DIABETIC NEUROPATHIES; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERGLYCEMIA; MALE; MIDDLE AGED; NERVOUS SYSTEM DISEASES; REFRACTORY PERIOD, ELECTROPHYSIOLOGICAL; TIME FACTORS;

EID: 4644246527     PISSN: 13882457     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinph.2004.06.008     Document Type: Article

References (21)

1. Bostock H., Cikurel K., Burke D. Threshold tracking techniques in the study of human peripheral nerve. Muscle Nerve. 21:1998;137-158
2. Braume H.-J. Testing of the refractory period in sensory nerve fibers is the most sensitive method to assess beginning polyneuropathy in diabetics. Electromyogr Clin Neurophysiol. 39:1999;355-359
3. Brismar T. Abnormal Na-currents in diabetic rat nerve nodal membrane. Diabet Med. 10:(Suppl 2):1993;S110-S112
4. Brismar T., Sima A.A.F., Greene D.A. Reversible and irreversible nodal dysfunction in diabetic neuropathy. Ann Neurol. 21:1987;504-507
5. Burke D., Kiernan M.C., Bostock H. Excitability of human axons. Clin Neurophysiol. 112:2001;1575-1585
6. Dyck P.J., Lais A., Karnes J.L., O'Brien P., Rizza R. Fiber loss is primary and multifocal in sural nerves in diabetic polyneuropathy. Ann Neurol. 19:1986;425-439
7. Dyck P.J., Giannini C. Pathologic alterations in the diabetic neuropathies of humans: a review. J Neuropathol Exp Neurol. 55:1996;1181-1193
8. Greene D.A., Arezzo J.C., Brown M.B. The Zenarestat Study. Effect of aldose reductase inhibition on nerve conduction and morphometry in diabetic neuropaty Group. Neurology. 53:1999;580-591
9. Kiernan M.C., Bostock H. Effects of membrane polarization and ischaemia on the excitability properties of human axons. Brain. 123:2000;2542-2551
10. Kiernan M.C., Burke D., Andersen K.V., Bostock H. Multiple measures of axonal excitability: a new approach in clinical testing. Muscle Nerve. 23:2000;399-409
11. Kiernan M.C., Walters R.J., Andersen K.V., Taube D., Murray N.M., Bostock H. Nerve excitability changes in chronic renal failure indicate membrane depolarization due to hyperkalaemia. Brain. 125:2002;1366-1378
12. Kuwabara S. Shortened refractory periods in human diabetic neuropathy. Clin Neurophysiol. 114:2003;169-170
13. Kuwabara S., Ogawara K., Sung J.-Y., et al. Differences in membrane properties of axonal and demyelinating Guillain-Barré syndromes. Ann Neurol. 52:2002;180-187
14. Mackel R., Brink E. Conduction of neural impulses in diabetic neuropathy. Clin Neurophysiol. 114:2003;248-255
15. Quasthoff S. The role of axonal ion conductances in diabetic neuropathy: a review. Muscle Nerve. 21:1998;1246-1255
16. Shefner J.M., Dawson D.M. The use of sensory action potentials in the diagnosis of peripheral nerve disease. Arch Neurol. 47:1990;341-348
17. Sima A.A.F., Brismar T. Reversible diabetic nerve dysfunction: structural correlates to electrophysiological abnormalities. Ann Neurol. 18:1985;21-29
18. Sima A.A.F., Lattimer S.A., Yagihashi S., Greene D.A. Axo-glial dysjunction. A novel structural lesion that accounts for poorly reversible slowing of nerve conduction in the spontaneously diabetic bio-breeding rat. J Clin Invest. 77:1986;474-484
19. Sima A.A.F., Nathaniel V., Bril V., McEwen T.A., Greene D.A. Histopathological heterogeneity of neuropathy in insulin-dependent and non-insulin-dependent diabetes, and demonstration of axo-glial dysjunction in human diabetic neuropathy. J Clin Invest. 81:1988;349-364
20. Strupp M., Bostock H., Weigl P., Piwernetz K., Renner R., Grafe P. Is resistance to ischaemia of motor axons in diabetic subjects due to membrane depolarization? J Neurol Sci. 99:1990;271-280
21. Yasuda H., Dyck P.J. Abnormalities of endoneurial microvessels and sural nerve pathology in diabetic neuropathy. Neurology. 37:1987;20-28